Clal Biotechnology (Israel) Market Value
| CBI Stock | 35.20 0.20 0.57% |
| Symbol | Clal |
Clal Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Clal Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Clal Biotechnology.
| 11/12/2024 |
| 12/12/2024 |
If you would invest 0.00 in Clal Biotechnology on November 12, 2024 and sell it all today you would earn a total of 0.00 from holding Clal Biotechnology Industries or generate 0.0% return on investment in Clal Biotechnology over 30 days. Clal Biotechnology is related to or competes with Kamada, BioLine RX, Evogene, Bezeq Israeli, and Compugen. Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-c... More
Clal Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Clal Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Clal Biotechnology Industries upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 16.36 | |||
| Value At Risk | (5.08) | |||
| Potential Upside | 4.28 |
Clal Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clal Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Clal Biotechnology's standard deviation. In reality, there are many statistical measures that can use Clal Biotechnology historical prices to predict the future Clal Biotechnology's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.66) | |||
| Treynor Ratio | (0.72) |
Clal Biotechnology Backtested Returns
Clal Biotechnology secures Sharpe Ratio (or Efficiency) of -0.0747, which signifies that the company had a -0.0747% return per unit of standard deviation over the last 3 months. Clal Biotechnology Industries exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Clal Biotechnology's mean deviation of 2.27, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.28, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Clal Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Clal Biotechnology is expected to be smaller as well. At this point, Clal Biotechnology has a negative expected return of -0.21%. Please make sure to confirm Clal Biotechnology's maximum drawdown, rate of daily change, and the relationship between the jensen alpha and kurtosis , to decide if Clal Biotechnology performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.38 |
Poor reverse predictability
Clal Biotechnology Industries has poor reverse predictability. Overlapping area represents the amount of predictability between Clal Biotechnology time series from 12th of November 2024 to 27th of November 2024 and 27th of November 2024 to 12th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Clal Biotechnology price movement. The serial correlation of -0.38 indicates that just about 38.0% of current Clal Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.38 | |
| Spearman Rank Test | -0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 0.67 |
Clal Biotechnology lagged returns against current returns
Autocorrelation, which is Clal Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Clal Biotechnology's stock expected returns. We can calculate the autocorrelation of Clal Biotechnology returns to help us make a trade decision. For example, suppose you find that Clal Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Clal Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Clal Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Clal Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Clal Biotechnology stock over time.
Current vs Lagged Prices |
| Timeline |
Clal Biotechnology Lagged Returns
When evaluating Clal Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Clal Biotechnology stock have on its future price. Clal Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Clal Biotechnology autocorrelation shows the relationship between Clal Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in Clal Biotechnology Industries.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Clal Stock
Clal Biotechnology financial ratios help investors to determine whether Clal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Clal with respect to the benefits of owning Clal Biotechnology security.